STUDY DESIGN OF ELIXIR, A MULTICENTER EUROPEAN PHASE III CLINICAL TRIAL AIMED TO TEST A GLUCOSE-SPARING PD SOLUTION WHERE GLUCOSE IS MOSTLY REPLACED WITH OSMO-METABOLIC AGENTS

• Published in: NEPHROLOGY DIALYSIS TRANSPLANTATION Vol. 35; p. 1459
• Main Authors: Kleophas, W, Bonomini, M, Divino, JC, Reboldi, G, Iacobelli, M, Arduini, A
• Format: Conference Proceeding
• Language: English
• Published: 2020
• Subjects: Medicin och hälsovetenskap